Strategies for commercial excellence
PA’s broad and deep commercial experience in life sciences enables our clients to maximise the value of their products and services. We help them to raise and prolong their scale of revenues, and quicken their time to profit by aggressively managing related costs. Throughout the life cycle of their commercial assets - from discovery through development and commercialisation to late-life-cycle management - there are many strategies at our disposal to achieve those goals.
Improving R&D effectiveness
The cost of research and development is increasing while blockbuster drugs are coming off patent without pipelines to replenish the lost revenue. PA works with R&D organisations to meet this challenge in a number of ways including: improving the management of science; planning and delivering development effectively through complex project management, establishment of good governance to facilitate local productivity within global rules, and effective management of clinical resources and other traditional bottlenecks; and creating dynamic and high performance organisations where cultural sensitivity, reward and recognition, and virtual collaborations are all employed to create sustained business transformation.
Enhancing supply chain performance
Life sciences firms need to improve the overall efficiency of their supply chain because of the strong link between supply chain effectiveness and profitability.PA works with our clients to help achieve excellence in the supply chain and all manufacturing related operations.
PA is unique in providing the combination of engineering, technology and management skills needed to improve clients’ businesses. This combination is essential to achieve a sustainable improvement in business process and asset management – resulting in lower cost, higher throughput or greater consistency in getting the product to the patient. We also understand that, unless all aspects of regulatory compliance are observed, manufacturers can be subject to profound commercial risk. PA knows how to deliver compliant solutions, having done substantial compliance work in the biotech, pharmaceutical and medical device sectors.
